Alliance for Aging Research advocates for Medicare coverage of early Alzheimer's drugs

Alliance for Aging Research advocates for Medicare coverage of early Alzheimer's drugsПодробнее

Poll: Voters Believe Medicare Beneficiaries Should Have Access to Early Alzheimer’s MedicationsПодробнее

Medicare’s Coverage Decision: It’s Not Just About Alzheimer’sПодробнее

This Policy Would Have a Catastrophic Impact on Alzheimer’s Disease ResearchПодробнее

Webinar on Clinical Meaningfulness in Alzheimer's DiseaseПодробнее

This Is Growing Old: Navigating Neuropsychiatric Symptoms with Patient Advocate Terrie MontgomeryПодробнее

This is Growing Old: Living With Early Stages Alzheimer’s DiseaseПодробнее

Webinar: CMS's Coverage Decision: It's Not Just About Alzheimer's DiseaseПодробнее

Poll shows strong support for Medicare coverage of Alzheimer's drugsПодробнее

The History of the Alliance for Aging ResearchПодробнее

Experts on Neuropsychiatric Symptoms of Alzheimer’s: Carrie Shaw, CEO & Founder of Embodied LabsПодробнее

The History of the Alliance for Aging Research, Part IПодробнее

Heroes in Health: Full ProgramПодробнее

FDA approves Alzheimer's drug Leqembi, paving way for broader Medicare coverageПодробнее

This is Growing Old: Living with Early Onset Alzheimer’s Disease: Jay Reinstein Shares his StoryПодробнее

Alzheimer’s advocates rally for Medicare coverage of newly approved FDA treatmentsПодробнее

UsAgainstAlzheimer's Chairman and Co-Founder George VradenburgПодробнее

Webinar: Financing the Cure: Exploring the Ecosystem of Alzheimer’s Disease Research FundingПодробнее

The Emerging Antimicrobial Protection Hypothesis of Alzheimer's DiseaseПодробнее

Inside Alzheimer’s Research: New Medications and Innovative CareПодробнее